Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: update on a COVID era ILROG collaborative report
Year: 2023
Type: article
Abstract: Purpose/Objectives: During COVID19, shorter radiation therapy (RT) courses were considered to minimize patient exposure, ensure staff safety, and conserve healthcare resources.Due to concerns with the safety of systemic therapy, RT demands were also increased.In response, guidelines were published by the International Lymphoma
Source: Hematological Oncology
DOI: 10.1002/hon.3164_458
Authors: J. Yang, J. Gunther, C. Hajj, A. Ng, J. L. Brady, S. Cheng, M. Levis, S. Qi, N G. Mikhaeel, U. Ricardi, T. Illidge, A. Turin, M. Knafl, L. Specht, B. Dabaja, J. Yahalom
Institutions: Washington University in St. Louis, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Guy's Hospital, University of Manchester, University of Turin, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, The Christie NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, Copenhagen University Hospital, Rigshospitalet
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4379981805